These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 3008051

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Significance of CA 125 antigen levels in patients with ovarian cancer].
    Shimizu Y, Fujiwara H, Akagaki E, Hirota K, Kono M, Irie T, Miura S, Okudaira Y.
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):46-52. PubMed ID: 3455806
    [Abstract] [Full Text] [Related]

  • 8. Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors.
    Engelen MJ, de Bruijn HW, Hollema H, ten Hoor KA, Willemse PH, Aalders JG, van der Zee AG.
    Gynecol Oncol; 2000 Jul; 78(1):16-20. PubMed ID: 10873403
    [Abstract] [Full Text] [Related]

  • 9. CA 125 for the monitoring of ovarian carcinoma during primary therapy.
    Lavin PT, Knapp RC, Malkasian G, Whitney CW, Berek JC, Bast RC.
    Obstet Gynecol; 1987 Feb; 69(2):223-7. PubMed ID: 2433652
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Relationship of serum CA125 and lipid-associated sialic acid tumor-associated antigen levels to the disease status of patients with gynecologic malignancies.
    Stratton JA, Rettenmaier MA, Phillips HB, Herabutya S, DiSaia PJ.
    Obstet Gynecol; 1988 Jan; 71(1):20-6. PubMed ID: 2827081
    [Abstract] [Full Text] [Related]

  • 12. Clinical significance of cancer antigen 125 (CA 125) in ovarian cancer.
    Crombach G, Zippel HH, Würz H.
    Cancer Detect Prev; 1985 Jan; 8(1-2):135-9. PubMed ID: 3864535
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Preoperative evaluation of serum CA 125 levels in patients with primary epithelial ovarian cancer.
    Einhorn N, Bast RC, Knapp RC, Tjernberg B, Zurawski VR.
    Obstet Gynecol; 1986 Mar; 67(3):414-6. PubMed ID: 2418395
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Experiences with CA 125, a tumor marker for malignant epithelial ovarian tumors].
    Crombach G, Zippel HH, Würz H.
    Geburtshilfe Frauenheilkd; 1985 Apr; 45(4):205-12. PubMed ID: 2408962
    [Abstract] [Full Text] [Related]

  • 18. CA-125 monitoring in the management of ovarian cancer.
    Bruzzone M, Onetto M, Campora E, Chiara S, Oliva C, Guido T, Merlini L, Parodi S, Bentivoglio G, Ventrella W.
    Anticancer Res; 1990 Apr; 10(5A):1353-9. PubMed ID: 2241112
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Preoperative value of CA 125 as a reflection of tumor grade in epithelial ovarian cancer.
    But I, Gorisek B.
    Gynecol Oncol; 1996 Nov; 63(2):166-72. PubMed ID: 8910622
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.